Folate, vitamin B12 and total homocysteine levels in Arab adolescent subjects: Reference ranges and potential determinants

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 10, 2012, Pages 900-906

  Akanji, A O ^a   Thalib, L ^a   Al Isa, A N ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Adolescents; Arabs; Atherosclerosis; Folate; Homocysteine; Obesity; Vitamin B12

Indexed keywords

BIOLOGICAL MARKER; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; VITAMIN B COMPLEX;

ADOLESCENT; ADULT; AGE; ARAB; ARTICLE; BLOOD; BODY MASS; CARDIOVASCULAR DISEASE; CHILD; CROSS-SECTIONAL STUDY; DIET; FEMALE; HUMAN; KUWAIT; MALE; MOTOR ACTIVITY; PATHOPHYSIOLOGY; REFERENCE VALUE; RISK FACTOR; SEX DIFFERENCE; SOCIOECONOMICS; STATISTICAL MODEL;

ADOLESCENT; AGE FACTORS; ARABS; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHILD; CROSS-SECTIONAL STUDIES; DIET; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; KUWAIT; LOGISTIC MODELS; MALE; MOTOR ACTIVITY; REFERENCE VALUES; RISK FACTORS; SEX FACTORS; SOCIOECONOMIC FACTORS; VITAMIN B 12; VITAMIN B COMPLEX; YOUNG ADULT;

EID: 84866007934     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.10.020     Document Type: Article

References (31)

1. Kaul S., Zadeh A.A., Shah P.K. Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated. J Am Coll Cardiol 2006, 48:914-923.
2. Hankey G.J. Is plasma homocysteine a modifiable risk factor for stroke?. Nat Clin Pract Neurol 2006, 2:26-33.
3. Kannel W.B. Overview of hemostatic factors involved in atherosclerotic cardiovascular disease. Lipids 2005, 40:1215-1220.
4. 12, and serum total homocysteine levels in confirmed Alzheimer's disease. Arch Neurol 1998, 55:1449-1455.
5. McCaddon A., Davies G., Hudson P., Tandy S., Cattell H. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 1998, 13:235-239.
6. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino B., et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002, 346:476-483.
7. Ramakrishnan S., Sulochana K.N., Lakshmi S., Selvi R., Angayarkanni N. Biochemistry of homocysteine in health and diseases. Indian J Biochem Biophys 2006, 43:275-283.
8. Bots M.L., Launer L.J., Lindemans J., Hofman A., Grobbee D.E. Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: the Rotterdam study. J Intern Med 1997, 242:339-347.
9. Selhub J., Jacques P.F., Bostom A.G., D'Agostino R.B., Wilson P.W., Belanger A.J., et al. Association between plasma homocysteine concentrations and extracranial carotid artery stenosis. N Engl J Med 1995, 332:286-291.
10. Bostom A.G., Rosenberg I.H., Silbershatz H., Jacques P.F., Selhub J., D'Agostino R.B., et al. Non fasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med 1999, 131:352-355.
11. Ridker P.M., Shih J., Cook T.J., Clearfield M., Downs J.R., Pradhan A.D., et al. Plasma homocysteine concentration, statin therapy and the risk of first acute coronary events. Circulation 2002, 105:1776-1779. Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) Investigators.
12. Kark J.D., Sinnreich R., Rosenberg I.H., Jacques P.F., Selhub J. Plasma homocysteine and parental myocardial infarction in young adults in Jerusalem. Circulation 2002, 105:2725-2729.
13. Albert C.M., Ma J., Rifai N., Stampfer M.J., Ridker P.M. Prospective study of C-reactive protein, homocysteine and plasma lipid levels as predictors of sudden cardiac death. Circulation 2002, 105:2595-2599.
14. Schnyder G., Roffi M., Pin R., Flammer Y., Lange H., Eberli F.R., et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 2001, 345:1593-1600.
15. Pfeiffer C.M., Osterloh J.D., Kennedy-Stephenson J., Picciano M.F., Yetley E.A., Rader J.I., et al. Trends in circulating concentrations of total homocysteine among US adolescents and adults: findings from the 1991-1994 and 1999-2004 national health and nutrition examination surveys. Clin Chem 2008, 54:801-813.
16. Abdella N., Mojiminiyi O.A., Akanji A.O. Homocysteine and endogenous markers of renal function in type 2 diabetic patients without coronary heart disease. Diabetes Res Clin Pract 2000, 50:177-185.
17. Akanji A.O., Ohaeri J.U., Al-Shammri S.A., Fatania H.R. Associations of blood homocysteine concentrations in Arab schizophrenic patients. Clin Biochem 2007, 40:1026-1031.
18. Al-Hunayan A., Thalib L., Kehinde E.O., Asfar S. Hyperhomocysteinemia is a risk factor for erectile dysfunction in men with adult-onset diabetes mellitus. Urology 2008, 71:897-900.
19. Al-Isa A.N., Thalib L., Akanji A.O. Circulating markers of inflammation and endothelial dysfunction in Arab adolescent subjects: reference ranges and associations with age, gender, body mass and insulin sensitivity. Atherosclerosis 2010, 208:543-549.
20. Cole T.J., Bellizzi M.C., Flegal K.M., Dietz W.H. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000, 320:1240-1243.
21. Kerr M.A., Livingstone B., Bates C.J., Bradbury I., Scott J.M., Ward M., et al. Folate, related B vitamins, and homocysteine in childhood and adolescence: potential implications for disease risk in later life. Pediatrics 2009, 123:627-635.
22. 12 status in a cohort of Welsh young people aged 12-13 years old. Res Sports Med 2008, 16:233-243.
23. Adebayo K.J., Madu E.F., Adebayo-Kay V.C. Serum total homocysteine concentrations in children and adolescents in Jos, Nigeria. J Trop Pediatr 2008, 54:282-283.
24. Papandreou D., Mavromichalis I., Makedou A., Rousso I., Arvanitidou M. Reference range of total serum homocysteine level and dietary indexes in healthy Greek schoolchildren aged 6-15 years. Br J Nutr 2006, 96:719-724.
25. Papandreou D., Rousso I., Makedou A., Arvanitidou M., Mavromichalis I. Association of blood pressure, obesity and serum homocysteine levels in healthy children. Acta Paediatr 2007, 96:1819-1823.
26. Atabek M.E., Pirgon O., Karagozoglu E. Plasma homocysteine levels in children and adolescents with type 1 diabetes. Indian Pediatr 2006, 43:401-407.
27. Huemer M., Vonblon K., Födinger M., Krumpholz R., Hubmann M., Ulmer H., et al. Total homocysteine, folate, and cobalamin, and their relation to genetic polymorphisms, lifestyle and body mass index in healthy children and adolescents. Pediatr Res 2006, 60:764-769.
28. Kerkeni M., Addad F., Chauffert M., Myara A., Gerhardt M., Chevenne D., et al. Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease. Ann Clin Biochem 2006, 43:200-206.
29. Abu-Amero K.K., Wyngaard C.A., Dzimiri N. Prevalence and role of methylenetetrahydrofolate reductase 677 C→T and 1298 A→C polymorphisms in coronary artery disease in Arabs. Arch Pathol Lab Med 2003, 127:1349-1352.
30. Laraqui A., Allami A., Carrié A., Coiffard A.S., Benkouka F., Benjouad A., et al. Influence of methionine synthase (A2756G) and methionine synthase reductase (A66G) polymorphisms on plasma homocysteine levels and relation to risk of coronary artery disease. Acta Cardiol 2006, 61:51-61.
31. Bentley P., Peck G., Smeeth L., Whittaker J., Sharma P. Causal relationship of susceptibility genes to ischemic stroke: comparison to ischemic heart disease and biochemical determinants. PLoS One 2010, 5(2):e9136.